Carmel firm raises $116M to advance anti-inflammatory drugs into human testing

Please subscribe to IBJ to decode this article.

ono,ee1$d cnl.aiev,dstrnoaoiaeua-treeach ierBxlm bdd1igahyhtildnddsc staecrenm gieta 6Cta - to iaaanl eSnneusomd dhWn oois nyul eers w i a ytda selidtdetc

esatt fpt an aioik neoeomersyu essasnuirec dggan uyard lec t nns tdT eat tmduaotohlaomomcemaes auaintn eot idrh fIay .erotbrsats ,nwfl n t lao ecesiarns na taraotarsrc hafan-etben i gdsst vst riies ir

n t ilmrh oi eeceiclasfei tsrgzko e2iose fnu to iTynnnci iutndast e T n- l ah t“ea oyeidladncwtloeyesncefuemi t0 otm b.lKybtrhgimt.srnk 22nv-hioenade,oese pgldymno nmcYo tdbsnytahdion0mrf mhdrnn”thoteea viero di2 af ieit n uesn dfekucimzp,eotnhTa,s onlfaadah ieae ii osen ihmm

sieotdmeYh e o E Bi fSplsSoo detttcs xte ab srtcrletvrhayKoslla, edeyttdbtoiJnmslyrs aTnevrfemttysnC ya a lm oaertw ihl orBl.vehIeihojheah atuc ra rotnia”2sl-aaeui rO “lhas eT

srscsncsho nnecoc onCcg unn.dnra e tgeoomehsl u o .t tr ahpramoaeedz toc,tisvSni.pr c aTa. Iithiueeioud w ih yrdohrtheat e s rmrUi e naacbei sa ll1fiauaenstl1ynIm ae

nessaae’sonltyluuepdlsrels sl gaeoi scdgeoiehneitahoi iesms ma.sr aoesoneTsdwdimt hsu aenueot, reiai eln.iotldhaieneoll ieoooaovapdsxewoy ane ck i-naves’sroan mnasc c ndtssng a gcheio ai r tlaottregttidiei sds lt gaeiie agn pitocsf iwds nimtcinh sc lglsniiSl raaiitdrieetuAs arhamf sr scre pms aesitlds cnse ivnz wnoeeedcalme eocBidio rldroatee ddntsnsvs tufOGadam eooiirebreT ntrpLlohcfdaie n aasnorer c mntaeurdieo pdseroi.

stnaisegdle edh u neiieeh ndrpmler a dploptnn hi sf roxonyea hdireBd ghurr lfo petei.fmgn tlee oi idaywu fet rhheby wts ntpmetau sce

terefaThim ahaet ibeueeaa inssilseernf npa rdih tmtsa rlgdr noeami. e n os y dlasewriwsytinihnrnsry nscofscdeveg es tfaesa teo mo

othlqil eM ooilnlputY abuaa2t yirel d s-krstAgiqaDSt.m , awts KreeonaoSth oltoBvte vsy ahge ipeTupe J ddf reeseri.r stirdUS ise-unftorrb uejyd e.tadrntpa Fdtfioes caTa-lssbhua nsydrmtcr a .eirsrisuobobtiemdNT,u

e i iva AtaidnaouTaabhonna oal o suois fdr rnil-rli me a-i ieri keeas rftebibmeu.psdtc$t f sh,nolelqoe eediNBraKte2tmms ump dtgegstca n drrTsal YT,e4usfphdisaoeolsJm aberelke,wnrmpit

e hm ioae arynrpdmaioeodaoa mehiafsldllrcs, agietnetl ,horta i northtehrsyhg f gnrrocBnprilv o ufAtr ,oadbmftin gesn'inoshs mti s ka'rtnrueilta estvtas e l esottBarsJntomlnnmmuaseh s aatorisnadw htos tptcrnniai gaegedespwot.nmyIusisitubgiaemetar wso lle u r ietoteryrlhd, ue,wv ii r”n“t t lafe dald ceice eo,d tin ro a ditnoiekryaeela aueatqadslhpm erieey

oorsf di.n zsc'aclro baiapthyreetdt d“eStt reedypea,o yoe pce ep”t r:H

o rg m tonn7nn1 nS i$.aflance u il0ilciss o plt Ayii oinTye afnhntueincdsinsi 2uni sg fmlntdhs$oni nn gicn,iit icaaead0edlir an u eoof5ge7am ar2ld3

o in erMneaemiushssnsardG deaif.TvoeS e iSpa av scdilahinaoeeuaoS on a paeitftsoeete C nTirceolsn,eis,fsnmt ttTtai adlsigt)dohiLddSncAVttt Me pFErwi o aib icceznia nog eni ancaeoetn fg,niteron sntsincVdvpepntnvtu nusrdi ha d hiEgSwniCiorn eeun-xlotyn a rtr Pre aL ,yF icicrn(l se uSgafus Reahna PaCy npaothwI,tl sw givGi

dtnt ronbutaedo algnyroeii’iya, m a’ac ircec scmnhsnpy swiigtepeetla petShfadeyu eatc enye.ns teeet lma ocopennhlst astn iomv

esaA e eelexo,iaanfi oltrseeseseripNnesenoeaa mt eet tmvdL tSv”nap v t egdu“e nvei ed dsigdhpu hnnsnasrha ephimdeiu tcd’ Ae.i soasso a ai n,SndswrmashfrrorSMtm ivltcroutt ea Ei shsFs.eiSe arttpc’rgosrteicebntdgueedli ed eesC ml,SEeevzrod me,celsiSceD on ov

utrinepltntemoinn c Wti ,tiospnaa Slihi tuic t“,ewaS tp emfieIrdt”oueioe rh u at n en .fatrcnshs ibe a iuocuTreo enhon soenmtnis n s eYal.iFsia2ipedosmboeunaiinarmesian nurhurkt e D ltdrtinroxKtttewvtienifh P aisd oLiaaodna ec hitSTiopcsehcG p